1-6 of 6
Jeannine Margolis
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Mosunetuzumab with response-driven lenalidomide augmentation achieves high response rates and immune reprogramming in untreated follicular and marginal zone lymphoma: A multicenter Phase 2 trial

Free
Adam Olszewski, Matthew Matasar, Scott Huntington, Dennis Bonal, Thomas Ollila, Ari Pelcovits, Yun Kyoung Tiger, John Reagan, Anna Chorzalska, John Morgan, Makayla Pardo, Jessica McMahon, Stephen Donnelly, Caylee Carmody, Jeannine Margolis, Charles Milrod, Patrycja Dubielecka
Journal: Blood
Blood (2025) 146 (Supplement 1): 1003.
https://doi.org/10.1182/blood-2025-1003
Published: 2025
Journal Articles

Baseline data from the prioritizing utilization and safety of hydroxyurea using precision in Africa (PUSHUP) trial

Free
Christine Briscoe, Margarida Muhongo Texeira, Eugênia Mateus, Yolanda Aguilera, Wilma Faustino, Arnaldo Patrocinio, Claudia Halumbala, Morena da Costa, Daniel Púcuta, Jeannine Margolis, Roxanne Wood, Amy Webber, Manpreet Kochhar, Lydia Musula, Joshua Tanzer, Patrick McGann
Journal: Blood
Blood (2025) 146 (Supplement 1): 4718.
https://doi.org/10.1182/blood-2025-4718
Published: 2025
Journal Articles

Mosunetuzumab with Response-Driven Lenalidomide Augmentation As First-Line Therapy for Symptomatic Follicular or Marginal Zone Lymphoma: Interim Analysis of a Multi-Center Phase 2 Study

Free
Adam J. Olszewski, Matthew Matasar, Scott F Huntington, Thomas Ollila, Ari Pelcovits, Yun Kyoung Tiger, John L. Reagan, Anna Dorota Chorzalska, John Morgan, Makayla R Pardo, Jessica McMahon, Stephen Donnelly, Caylee Carmody, Jeannine Margolis, Charles Milrod, Patrycja M. Dubielecka
Journal: Blood
Blood (2024) 144 (Supplement 1): 1644.
https://doi.org/10.1182/blood-2024-193022
Published: 2024
Journal Articles

Circulating Biomarkers and CD8+ T-Cell Subpopulations Reveal Evolving Phases of Immune Response in Patients Receiving Mosunetuzumab for Previously Untreated B-Cell Lymphoma

Free
Charles Milrod, Anna Dorota Chorzalska, John Morgan, Makayla R Pardo, Christina Raker, Thomas Ollila, Seo-Ho Lee, Ari Pelcovits, John L. Reagan, Jessica McMahon, Stephen Donnelly, Caylee Carmody, Jeannine Margolis, Matthew Matasar, Scott F Huntington, Patrycja M. Dubielecka, Adam J. Olszewski
Journal: Blood
Blood (2024) 144 (Supplement 1): 1614.
https://doi.org/10.1182/blood-2024-193023
Published: 2024
Journal Articles

Fractionated Gemtuzumab Ozogamicin Followed By Non-Engraftment Donor Leukocyte Infusions for Relapsed/Refractory Acute Myeloid Leukemia

Free
John L. Reagan, Rabin Niroula, Jessica McMahon, Pamela Egan, Inna Yakirevich, Mandy Pereira, Ari Pelcovits, Jeannine Margolis, Ashlee Sturtevant, Peter J. Quesenberry, Loren D. Fast
Journal: Blood
Blood (2023) 142 (Supplement 1): 6874.
https://doi.org/10.1182/blood-2023-177759
Published: 2023
Journal Articles

Vincristine Sulfate Liposome Injection (VSLI) with Bendamustine and Rituximab As First-Line Therapy for Indolent B-Cell Lymphomas: A Phase 1 Study

Free
Thomas A Ollila, MD, James Butera, MD, Pamela C Egan, MD, John L Reagan, MD, Anthony G Thomas, DO, Inna Yakirevich, NP, Kelsey MacKinnon, Jeannine Margolis, Valerie Rosati, Jessica McMahon, RN, Jordan Robison, CRA, Adam J Olszewski, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 15–16.
https://doi.org/10.1182/blood-2020-134054
Published: 2020